News & Updates
Filter by Specialty:
Add-on ixazomib does not improve cyclophosphamide-dexamethasone combo in frail MM patients
17 May 2022
The addition of ixazomib to cyclophosphamide-dexamethasone treatment does not seem to result in better survival and response rates in patients with newly diagnosed and relapsed multiple myeloma (MM), a recent study has found.
Add-on ixazomib does not improve cyclophosphamide-dexamethasone combo in frail MM patients
17 May 2022Chamomile improves skin recovery in breast cancer patients with radiodermatitis
13 May 2022
A topical formulation containing chitosan-coated Chamomilla recutita (L.) rauschert microparticles does not lower any grade of radiodermatitis (RD) but is effective in reducing grade ≥2 toxicity to improve skin recovery and diminish high-intensity local symptoms in women with breast cancer, a study has shown.